Pathological examination revealed invasive ductal carcinoma measuring 1.8 cm, which was estrogen receptor (ER)-positive, progesterone receptor (PR)-positive, human epidermal growth factor receptor type 2 (HER2)-unknown and negative for lymph node involvement. Here, ERBB2 is linked to invasive ductal breast carcinoma.